Bristol Myers Squibb Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Bristol-Myers Squibb are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Bristol-Myers Squibb is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 15 B | |
| Total Cashflows From Investing Activities | -538 M |
Bristol-Myers |
Bristol-Myers Squibb Relative Risk vs. Return Landscape
If you would invest (100.00) in Bristol Myers Squibb on January 26, 2024 and sell it today you would earn a total of 100.00 from holding Bristol Myers Squibb or generate -100.0% return on investment over 90 days. Bristol Myers Squibb is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Bristol-Myers, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Bristol-Myers Squibb Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bristol-Myers Squibb's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Bristol Myers Squibb, and traders can use it to determine the average amount a Bristol-Myers Squibb's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BMYMP |
Based on monthly moving average Bristol-Myers Squibb is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bristol-Myers Squibb by adding Bristol-Myers Squibb to a well-diversified portfolio.
Bristol-Myers Squibb Fundamentals Growth
Bristol-Myers Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bristol-Myers Squibb, and Bristol-Myers Squibb fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bristol-Myers Pink Sheet performance.
| Revenue | 46.38 B | |||
| EBITDA | 20.1 B | |||
| Cash And Equivalents | 6.07 B | |||
| Cash Per Share | 3.72 X | |||
| Total Debt | 39.6 B | |||
| Debt To Equity | 59.40 % | |||
| Book Value Per Share | 7.55 X | |||
| Cash Flow From Operations | 16.21 B | |||
| Total Asset | 109.31 B | |||
Things to note about Bristol Myers Squibb performance evaluation
Checking the ongoing alerts about Bristol-Myers Squibb for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bristol Myers Squibb help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bristol Myers Squibb is not yet fully synchronised with the market data | |
| Bristol Myers Squibb has some characteristics of a very speculative penny stock | |
| Bristol Myers Squibb has a very high chance of going through financial distress in the upcoming years |
- Analyzing Bristol-Myers Squibb's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bristol-Myers Squibb's stock is overvalued or undervalued compared to its peers.
- Examining Bristol-Myers Squibb's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bristol-Myers Squibb's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bristol-Myers Squibb's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bristol-Myers Squibb's pink sheet. These opinions can provide insight into Bristol-Myers Squibb's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Bristol-Myers Pink Sheet
If you are still planning to invest in Bristol Myers Squibb check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bristol-Myers Squibb's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |